// App-Quantinova.ai

1186-310 : COMPARISON OF RIVAROXABAN OR WARFARIN USE FOR VENOUS THROMBOEMBOLISM ON INPATIENT LENGTH OF STAY

Researchers

Presenter

  • Steven Deitelzweig

Principal Investigators

  • Jeffrey Kline

  • Jay M. Margolis

  • Monika Raut

  • Oth Tran

  • David Smith

  • Concetta Crivera

  • Brahim Bookhart

  • Jeff Schein

  • William Olson

Medical Centers

  • Carolinas Medical Center, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • Hydroxyzine

  • apixaban

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved